Saturday, November 16, 2024
Happening Now

FDA panel votes against experimental ALS treatment pushed by patients

Federal health advisors voted 17-1 against an experimental treatment for Lou Gehrig’s disease dubbed NurOwn, although the FDA is not bound by the vote. Source

Share